A drug that shuts down a critical cell-signaling pathway in the most common and aggressive type of adult brain cancer successfully kills cancer stem cells thought to fuel tumor growth and help cancers evade drug and radiation therapy, a Johns Hopkins stud ...
Source:
Johns Hopkins Medical Institutions
Thursday, August 30, 2007